Dr Anjali Pathak discusses four cases of skin cancer or pre-cancer - involving potentially malignant skin lesions - and their management ...

Received folinic acid/fluorouracil/oxaliplatin/bevacizumab in first line with initial partial response; progression after 11 ...

The combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy did not help patients with metastatic ...

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...

A new study finds that vitamin B3 (nicotinamide) at 500 mg twice daily reduces basal cell carcinoma and squamous cell ...

Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients ...

A major shift is unfolding in the field of skin cancer prevention, ignited by new research showing that an everyday vitamin ...

WINSTON-SALEM, N.C. — Researchers at Wake Forest University's School of Medicine have developed a battery-free, chip-less ...

A massive Veterans Affairs study has confirmed that nicotinamide may offer real protection against skin cancer. Patients who ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...

Scientists have created a new light-based cancer therapy that targets tumors precisely without harming healthy cells.